Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02924298 · ClinicalTrials.gov registry record · NA
Effect of Sit Less, Interact, Move More (SLIMM) Regimen on Patients With Chronic Kidney Disease (CKD)
A NA study, sponsored by Srinvasan Beddhu.
- Terminated
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT02924298 is a NA study that was terminated before completion, run by Srinvasan Beddhu. The registered enrollment target is 32 participants.
The verdict
NCT02924298, a NA study, was terminated before completion, sponsored by Srinvasan Beddhu.
- TERMINATED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
In the past two decades, the prevalence of obesity in the US has increased from 23.2% to 32.9%. This epidemic is fueling the Chronic Kidney Disease (CKD) epidemic. This likely is the major challenge facing the nephrology community in the next decade and beyond. This pilot study is designed to test the feasibility of the Sit Less, Interact, Move More (SLIMM) intervention and to determine its preliminary impact on light physical activity (PA) levels. Increasing light PA may have significant impact on both obesity and slowing the progression of CDK.
Interventions
- BEHAVIORAL SLIMM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2013-09 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02924298
The ClinicalTrials.gov registry entry for NCT02924298 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Srinvasan Beddhu, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SLIMM is the first listed.
NCT02924298 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02924298 about?
NCT02924298 is a clinical study titled "Effect of Sit Less, Interact, Move More (SLIMM) Regimen on Patients With Chronic Kidney Disease (CKD)". In the past two decades, the prevalence of obesity in the US has increased from 23.2% to 32.9%. This epidemic is fueling the Chronic Kidney Disease (CKD) epidemic. This likely is the major challenge facing the nephrology community in the next decade and beyond. This pilot study is designed to test t...
What is the current status of trial NCT02924298?
This trial is currently terminated. It is a NA study. The enrollment target is 32 participants. The study started on 2013-09. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02924298?
The interventions under investigation include: SLIMM (BEHAVIORAL).
Who is sponsoring clinical trial NCT02924298?
This trial is sponsored by Srinvasan Beddhu, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.